Pharmaceutical Plant
| Client | Denka Co., Ltd. |
|---|---|
| Location | Niigata/ Japan |
| Completion | 2020 |
| Scope | EPC |
This project was undertaken to construct a new manufacturing facility for Influenza vaccine materials for DENKA SEIKEN Co., Ltd. with the aim of not only increasing the vaccine production capacity at the plant, but also to help bring about the establishment of a stable vaccine supply system.
The Group was awarded this project in 2018 as a result of various proposals that contributed to improving the economic efficiency for the client, including the introduction of automation to the raw material transportation and management process. Based on our advanced engineering skills and extensive experience in the construction of pharmaceutical manufacturing plants, we were able to successfully be completed this project in 2020.
The JGC Group will further respond to the diversifying and expanding medical needs in Japan and abroad, including a stable supply of vaccines, and contribute to improving the quality of people's lives.
